FeesSafety
Pluang+

Lichen International announces 1-for-100 reverse stock split effective Nov 20, 2026

Company Fundamentals
18 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Neutral
Lichen International announces 1-for-100 reverse stock split effective Nov 20, 2026

Lichen International Limited will implement a 1-for-100 reverse stock split of its Class A and Class B ordinary shares effective November 20, 2026. This move will reduce the number of outstanding shares significantly but will not change shareholders' percentage ownership. The par value per share will increase from $0.008 to $0.80, and the company's authorized share capital remains unchanged. Shareholders do not need to take any action as adjustments will be made automatically for those holding shares through brokers or banks.

Lichen International Limited's reverse stock split announcement is presented here with a snapshot of the Financials sector on Pluang as of Nov 18, 2026 19:21 WIB. Among 142 priced US Financials stocks, 73 rose and 59 fell. Notably, RIOT traded at USD 17.59 with a 3.17% gain but saw 89% sell orders, contrasting with OXLC at USD 4.95 which rose 2.70% and had 100% buy orders, while AVAT was priced much lower at USD 0.87 with a 2.85% increase and 91% sell orders.

More News

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's reported adjusted earnings per share of $3.10, surpassing estimates of $2.88, and revenue of $22.80 billion, beating the $22.40 billion forecast. Comparable sales rose 1.8%, driven by strong online and professional services sales. The company ...

Company Fundamentals
Bullish
49 minutes ago
Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Daxor Corporation announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital outpatient site using Daxor’s ezBVA Lab service. This expansion allows the outpatient clinic to receive bloo...

Market News
Bullish
54 minutes ago
Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
1 hour ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
1 hour ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App